Azithromycin
68 NDCs across 16 manufacturers|68 Generic,0 Brand
Azithromycin is used to treat bacterial infections, chlamydia infections, haemophilus infections, nontuberculous mycobacterium infections, neisseriaceae infections and otitis media, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 1, 1991, and the first generic was approved Nov 14, 2005. FDA's Orange Book lists 44 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $47 million on Azithromycin across 8.8 million claims for 6.3 million beneficiaries.
Azithromycin is available as 68 NDCs from 16 manufacturers (68 generic, 0 brand), with NADAC prices from $0.27 to $17.01 per EA — the most expensive product costs about 64× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
68
68G / 0B
Manufacturers
16
competing in market
Price Spread
$0.27 – $17.01
per EA, 48 of 68 NDCs
7d Activity
avg -2.3% WoW · of 68 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Teva Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Macrolide Antimicrobial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
16 manufacturers producing AZITHROMYCIN(3 pricing outliers)
Frequently Asked Questions
What is Azithromycin used to treat?
Azithromycin is used to treat bacterial infections, chlamydia infections, haemophilus infections, nontuberculous mycobacterium infections, neisseriaceae infections and otitis media, per the National Library of Medicine's MED-RT classification.
When did Azithromycin become available as a generic?
FDA approved the first generic Azithromycin (ANDA) on Nov 14, 2005. The Orange Book currently lists 44 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Azithromycin?
In 2024, Medicare Part D spent $47 million on Azithromycin across 8.8 million claims for 6.3 million beneficiaries.
How many Azithromycin products are on the market?
The Azithromycin drug market contains 68 NDCs from 16 manufacturers — 68 generic and 0 brand products.
What is the price range for Azithromycin?
NADAC reference prices for Azithromycin range from $0.2656 to $17.0133 per EA — the most expensive product costs about 64× the cheapest. 20 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Azithromycin?
16 manufacturers list Azithromycin in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (11), Aurobindo Pharma Limited (10), Bionpharma Inc. (7), Alembic Pharmaceuticals Inc. (5), Lupin Pharmaceuticals Inc. (5).
How has the price of Azithromycin changed recently?
Over the past 7 days, 5 Azithromycin NDCs rose and 60 fell, with a market-wide average change of -2.3%.